Thumbnail Image
Publication

Mesothelioma stratified therapy (MiST): a phase IIA umbrella trial for accelerating the development of precision medicines

Fennell, D
; 
Hudka, M
; 
Darlison, L
; 
Lord, K
; 
Bzura, A
; 
Dzialo, J
; 
Pritchard, C
; 
Harber, J
; 
Takata, T
; 
Popat, S
... show 10 more
Citations
Altmetric:
Abstract
Authors
Fennell, D
Hudka, M
Darlison, L
Lord, K
Bzura, A
Dzialo, J
Pritchard, C
Harber, J
Takata, T
Popat, S
Krebs, Matthew G
Nolan, L
Greystoke, A
Richards, C
Wells-Jordan, P
Branson, A
Gaba, A
Bhundia, V
Scotland, M
Mohamed, S
Dawson, A
Poille, C
Cowley, C
Walter, H
King, A
Thomas, A
Affiliation
Leicester Cancer Research Centre, University of Leicester & University Hospitals of Leicester, Leicester/GB
Description
Date
2019
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Fennell D, Hudka M, Darlison L, Lord K, Bzura A, Dzialo J, et al. P2.06-02 Mesothelioma Stratified Therapy (MiST): A Phase IIA Umbrella Trial for Accelerating the Development of Precision Medicines. Journal of Thoracic Oncology. 2019;14(10):S755-S6.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/622532
Embedded videos